Live Webinar on High Content Screening 23.03 - Advancing your knowledge to combat infectious diseases faster copy
Mar 14, 2021
3 min
High Content Screening - Advancing your knowledge to combat infectious diseases faster
Researchers worldwide are working around the clock to develop effective drugs and vaccines for the SARS-CoV-2 virus. Their efforts are largely focused around development of vaccines, new therapeutics and re-purposing of existing drugs.
High content screening (HCS), with its wide range of applications, is an important part of each of these strategies as it combines high-throughput automated cellular imaging with sophisticated image analysis to extract quantitative, multi-parametric data at the single-cell level. Join us for this webinar by Dr. Laurianne Davignon, where we look at several recent investigations in which HCS is/was used to target SARS-CoV-2 and other deadly viruses.
DATE: 23 March 2021
TIME: 9 AM CET
DURATION: 1 Hour
Key Learning objectives you will gain from attending this webinar:
• Learn how researchers are employing HCS to make great strides in the fight against deadly viruses
• Glean upon recent development/s of effective treatments for COVID-19 and other viral diseases that might emerge in the future
• Learn how our High Content systems allow researchers to investigate the biological mechanisms underlying disease progression
PRESENTER:
Laurianne Davignon
Subject Matter Expert, In Vivo Imaging
PerkinElmer Inc
Share
Company
Nova Natura UAB
Kaštonų g. 56, Giraitės k, LT-54310, Kaunas, Lithuania
